Search the GHTC website

Global health R&D delivers for Kansas

US government investment in global health R&D has delivered

$17.7 million
to Kansas research institutions
200+ new jobs
for Kansas
Global health R&D at work in Kansas

Researchers at the University of Kansas (KU) are working to develop a low-cost vaccine manufacturing platform for use in the world’s poorest nations. The researchers are collaborating with partners to standardize the development of new vaccines. Their goal is to create several vaccine candidates that cannot only be produced inexpensively but also remain stable to ensure their potency during storage, transport, and distribution. Affordable and reliable vaccines are a crucial element of disease prevention programs around the world. Delivered effectively, they can save lives and improve the health of entire populations. The KU team is also working on a needle-free vaccination method to be used with several currently available vaccines.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: PATH/Gabe Bienczycki